- Home
- MRNA vs MKSI Comparison
MRNA vs MKSI Comparison
Compare MRNA & MKSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | MKSI |
|---|---|---|
| Founded | 2010 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7B | 16.4B |
| IPO Year | 2018 | 1997 |
Fundamental Metrics
Financial Performance| Metric | MRNA | MKSI |
|---|---|---|
| Price | $47.86 | $209.32 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 13 |
| Target Price | $33.00 | ★ $255.62 |
| AVG Volume (30 Days) | ★ 7.2M | 1.1M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.45% |
| EPS Growth | 21.77 | ★ 55.52 |
| EPS | N/A | ★ 4.37 |
| Revenue | ★ $19,263,000,000.00 | $3,931,000,000.00 |
| Revenue This Year | $8.59 | $15.64 |
| Revenue Next Year | $16.72 | $10.58 |
| P/E Ratio | ★ N/A | $51.19 |
| Revenue Growth | 4.29 | ★ 9.62 |
| 52 Week Low | $22.28 | $54.84 |
| 52 Week High | $59.55 | $269.91 |
Technical Indicators
Market Signals| Indicator | MRNA | MKSI |
|---|---|---|
| Relative Strength Index (RSI) | 43.34 | 40.02 |
| Support Level | $48.09 | $209.20 |
| Resistance Level | $55.20 | $246.35 |
| Average True Range (ATR) | 2.53 | 12.29 |
| MACD | -0.85 | -1.29 |
| Stochastic Oscillator | 10.52 | 5.53 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About MKSI MKS Instruments Inc.
MKS Inc delivers foundational technology solutions for leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. The company provides instruments, components, subsystems, systems, process control solutions, and specialty chemicals technology that improve process performance and optimize productivity. Its solutions address challenges of miniaturization and complexity in device manufacturing, enabling increased power, speed, and feature enhancement. MKS Inc operates through three divisions: Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Materials Solutions Division (MSD). The company operates in the United States, which generates maximum revenue, as well as China and other countries.